Back to Search
SALMAN SHAFIQ, MD
MD
Internal Medicine Physician
NPI: 1376570648IndividualAccepts Medicare
Education
OTHER
Class of 1984
Research & Publications (14)
Enhanced anti-inflammatory effects of celecoxib from a transdermally applied nanoemulsion.
PMID 19435145·Pharmazie·2009
7-preclinical
Celecoxib nanoemulsion: skin permeation mechanism and bioavailability assessment.
PMID 18985507·J Drug Target·2008
7-preclinical
Enhanced stability of ramipril in nanoemulsion containing cremophor-EL: a technical note.
PMID 18958628·AAPS PharmSciTech·2008
8-other
Skin permeation mechanism of aceclofenac using novel nanoemulsion formulation.
PMID 18771006·Pharmazie·2008
7-preclinical
Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion.
PMID 18613981·J Nanobiotechnology·2008
8-other
Nanoemulsions as vehicles for transdermal delivery of aceclofenac.
PMID 18181525·AAPS PharmSciTech·2007
7-preclinical
Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib.
PMID 17878111·Acta Pharm·2007
7-preclinical
Development and bioavailability assessment of ramipril nanoemulsion formulation.
PMID 17127045·Eur J Pharm Biopharm·2007
4-observational
Differential effects of doxorubicin on atrial natriuretic peptide expression in vivo and in vitro.
PMID 11715857·Biol Res·2001
7-preclinical
Ventricular myosin light chain-2 gene expression in developing heart of chicken embryos.
PMID 11471518·Biol Res·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 333 SMITH AVE N, SUITE 4314A
SAINT PAUL, MN 55102 - Phone
- (651) 241-8451
Quick Facts
- NPI
- 1376570648
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 42
- Publications
- 14
Are you this provider?
Claim Your Profile